Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | March 27, 2024 12:31pm

Gainers

  • Stoke Therapeutics (NASDAQ:STOK) shares increased by 46.1% to $15.03 during Wednesday's regular session. The company's market cap stands at $671.1 million. As per the press release, Q4 earnings came out 2 days ago.
  • Lixte Biotechnology (NASDAQ:LIXT) shares rose 43.68% to $3.24. The company's market cap stands at $7.2 million.
  • Nuvation Bio (NYSE:NUVB) shares moved upwards by 35.41% to $3.9. The company's market cap stands at $854.2 million.
  • Ontrak (NASDAQ:OTRK) shares moved upwards by 29.18% to $0.55. The market value of their outstanding shares is at $15.2 million.
  • PAVmed (NASDAQ:PAVM) stock increased by 25.72% to $2.59. The market value of their outstanding shares is at $20.8 million. The company's, Q4 earnings came out yesterday.
  • Nutriband (NASDAQ:NTRB) stock rose 24.33% to $3.78. The market value of their outstanding shares is at $31.9 million.

Losers

  • Akili (NASDAQ:AKLI) stock declined by 18.8% to $0.31 during Wednesday's regular session. The company's market cap stands at $24.3 million.
  • Mesoblast (NASDAQ:MESO) shares declined by 12.85% to $3.42. The company's market cap stands at $347.5 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) stock fell 11.19% to $0.44. The company's market cap stands at $1.7 million. As per the news, the Q4 earnings report came out 3 days ago.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares fell 11.08% to $2.73. The market value of their outstanding shares is at $14.8 million.
  • Fresh2 Group (NASDAQ:FRES) shares declined by 10.6% to $0.57. The market value of their outstanding shares is at $13.5 million.
  • PDS Biotechnology (NASDAQ:PDSB) shares decreased by 9.94% to $4.04. The company's market cap stands at $125.5 million. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AKLI FRES LIXT MESO NTRB NUVB OTRK PAVM PDSB SLRX STOK XTLB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist